{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:54:29Z","timestamp":1791982469062,"version":"4.4.0"},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Cerebral malaria (CM) is a lethal complication of Plasmodium falciparum infection. The multifactorial pathogenesis of the disease involving parasitic invasion of erythrocytes and sequestration of infected erythrocytes within the cerebral blood vessels leading to neuroinflammation and blood\u2013brain barrier (BBB) disruption demands a multi-pronged treatment strategy. This article gives a brief overview of the pathogenesis of CM, challenges associated with its treatment and potential strategies to combat the same.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Key findings<\/jats:title>\n                  <jats:p>There are several roadblocks in the successful treatment of CM. Resistance to artemisinin-based therapies has been reported in malaria-endemic regions. The paucity of targeted delivery to the brain necessitates the administration of antimalarials such as quinine in large doses causing toxic effects. There is a need for compounds to prevent oxidative stress, neuroinflammation and BBB disruption to decrease the menace of neurological sequelae associated with CM.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Summary<\/jats:title>\n                  <jats:p>Extensive research endeavours are now oriented towards investigating compounds that can act against neuroinflammation; developing brain-targeted nanocarriers to selectively deliver therapeutics against CM; and repurposing existing drugs and a combination of antimalarial and anti-inflammatory or immunomodulatory molecules for the treatment of CM. Protocols for evaluating novel proposed therapies against CM should be revisited to integrate monitoring of neurological parameters in parallel with the estimation of parasite load and survival.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jpp\/rgac003","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T20:12:19Z","timestamp":1643746339000},"page":"800-811","source":"Crossref","is-referenced-by-count":7,"title":["Emerging avenues for the management of cerebral malaria"],"prefix":"10.1093","volume":"74","author":[{"given":"Nivedita","family":"Das","sequence":"first","affiliation":[{"name":"Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM\u2019s NMIMS , Vile Parle (W), Mumbai ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6163-4128","authenticated-orcid":false,"given":"Priyanka","family":"Prabhu","sequence":"additional","affiliation":[{"name":"Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM\u2019s NMIMS , Vile Parle (W), Mumbai ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"key":"2024103012174530900_CIT0001","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm.3073","article-title":"Malaria biology and disease pathogenesis: insights for new treatments","volume":"19","author":"Miller","year":"2013","journal-title":"Nat Med"},{"key":"2024103012174530900_CIT0002","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/35100540","article-title":"Towards a blood-stage vaccine for malaria: are we following all the leads?","volume":"1","author":"Good","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"2024103012174530900_CIT0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2045-8118-11-1","article-title":"Host matrix metalloproteinases in cerebral malaria: new kids on the block against blood\u2013brain barrier integrity?","volume":"11","author":"Polimeni","year":"2014","journal-title":"Fluids Barriers CNS"},{"key":"2024103012174530900_CIT0004","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/cc2183","article-title":"Clinical review: severe malaria","volume":"7","author":"Trampuz","year":"2003","journal-title":"Crit Care"},{"key":"2024103012174530900_CIT0005","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.pt.2019.04.010","article-title":"Blood\u2013brain barrier in cerebral malaria: pathogenesis and therapeutic intervention","volume":"35","author":"Nishanth","year":"2019","journal-title":"Trends Parasitol"},{"key":"2024103012174530900_CIT0006","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1128\/AAC.00488-13","article-title":"Transdermal glyceryl trinitrate as an effective adjunctive treatment with artemether for late-stage experimental cerebral malaria","volume":"57","author":"Orjuela-S\u00e1nchez","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2024103012174530900_CIT0007","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.4049\/jimmunol.1400089","article-title":"Vitamin D inhibits the occurrence of experimental cerebral malaria in mice by suppressing the host inflammatory response","volume":"193","author":"He","year":"2014","journal-title":"J Immunol"},{"key":"2024103012174530900_CIT0008","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1475-2875-11-35","article-title":"Human cerebral malaria and Plasmodium falciparum genotypes in Malawi","volume":"11","author":"Milner","year":"2012","journal-title":"Malaria J"},{"key":"2024103012174530900_CIT0009","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fcimb.2015.00075","article-title":"Pathogenesis of cerebral malaria: new diagnostic tools, biomarkers, and therapeutic approaches","volume":"5","author":"Sahu","year":"2015","journal-title":"Front Cell Infect Microbiol"},{"key":"2024103012174530900_CIT0010","doi-asserted-by":"crossref","first-page":"e20181026","DOI":"10.1542\/peds.2018-1026","article-title":"Neurodevelopmental impairments 1 year after cerebral malaria","volume":"143","author":"Langfitt","year":"2019","journal-title":"Pediatrics"},{"key":"2024103012174530900_CIT0011","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12936-020-03336-z","article-title":"Pathophysiology and neurologic sequelae of cerebral malaria","volume":"19","author":"Schiess","year":"2020","journal-title":"Malar J"},{"key":"2024103012174530900_CIT0012","doi-asserted-by":"crossref","first-page":"e9164","DOI":"10.15252\/emmm.201809164","article-title":"Cerebral malaria is associated with differential cytoadherence to brain endothelial cells","volume":"11","author":"Storm","year":"2019","journal-title":"EMBO Mol Med"},{"key":"2024103012174530900_CIT0013","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.neurol.2019.07.008","article-title":"Human cerebral malaria: 2019 mini review","volume":"175","author":"Bruneel","year":"2019","journal-title":"Rev Neurol"},{"key":"2024103012174530900_CIT0014","doi-asserted-by":"crossref","first-page":"292471","DOI":"10.1155\/2014\/292471","article-title":"Reduction of experimental cerebral malaria and its related proinflammatory responses by the novel liposome-based \u03b2-methasone nanodrug","volume":"2014","author":"Guo","year":"2014","journal-title":"Biomed Res Int"},{"key":"2024103012174530900_CIT0015","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s00018-003-2347-x","article-title":"Tumor necrosis factor \u03b1 in the pathogenesis of cerebral malaria","volume":"60","author":"Gimenez","year":"2003","journal-title":"Cell Mol Life Sci"},{"key":"2024103012174530900_CIT0016","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.brainresbull.2020.01.020","article-title":"Molecular targets in cerebral malaria for developing novel therapeutic strategies.","volume":"157","author":"Vanka","year":"2020","journal-title":"Brain Res Bull"},{"key":"2024103012174530900_CIT0017","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.parint.2019.04.010","article-title":"Oral administration of coenzyme Q 10 protects mice against oxidative stress and neuro-inflammation during experimental cerebral malaria","volume":"71","author":"Nyariki","year":"2019","journal-title":"Parasitol Int"},{"key":"2024103012174530900_CIT0018","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/1475-2875-12-302","article-title":"Improvement of the efficacy of dihydroartemisinin with atorvastatin in an experimental cerebral malaria murine model","volume":"12","author":"Dormoi","year":"2013","journal-title":"Malar J"},{"key":"2024103012174530900_CIT0019","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10096-010-1122-9","article-title":"Peroxisome proliferator activating receptor (PPAR) in cerebral malaria (CM): a novel target for an additional therapy","volume":"30","author":"Balachandar","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2024103012174530900_CIT0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.drudis.2018.08.006","article-title":"New leads for drug repurposing against malaria","volume":"24","author":"Pazhayam","year":"2019","journal-title":"Drug Discov Today"},{"key":"2024103012174530900_CIT0021","first-page":"1378","article-title":"Combination therapy for malaria in Africa: hype or hope?","volume":"78","author":"Bloland","year":"2000","journal-title":"Bull World Health Organ"},{"key":"2024103012174530900_CIT0022","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.3390\/molecules23102527","article-title":"Polymeric nanocarriers for the delivery of antimalarials","volume":"23","author":"Mhlwatika","year":"2018","journal-title":"Molecules"},{"key":"2024103012174530900_CIT0023","doi-asserted-by":"crossref","first-page":"12671","DOI":"10.1038\/srep12671","article-title":"Simultaneously targeting inflammatory response and parasite sequestration in brain to treat experimental cerebral malaria","volume":"5","author":"Dende","year":"2015","journal-title":"Sci Rep"},{"key":"2024103012174530900_CIT0024","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1073\/pnas.0709715105","article-title":"High levels of erythropoietin are associated with protection against neurological sequelae in African children with cerebral malaria","volume":"105","author":"Casals-Pascual","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024103012174530900_CIT0025","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.intimp.2017.05.008","article-title":"Artesunate and erythropoietin synergistically improve the outcome of experimental cerebral malaria","volume":"48","author":"Du","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"2024103012174530900_CIT0026","doi-asserted-by":"crossref","first-page":"e1003099","DOI":"10.1371\/journal.ppat.1003099","article-title":"Statins decrease neuroinflammation and prevent cognitive impairment after cerebral malaria","volume":"8","author":"Reis","year":"2012","journal-title":"PLoS Pathog"},{"key":"2024103012174530900_CIT0027","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1128\/AAC.02591-12","article-title":"Potential efficacy of citicoline as adjunct therapy in treatment of cerebral malaria","volume":"58","author":"El-Assaad","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2024103012174530900_CIT0028","doi-asserted-by":"crossref","first-page":"e20210724","DOI":"10.1084\/jem.20210724","article-title":"Imatinib augments standard malaria combination therapy without added toxicity","volume":"218","author":"Chien","year":"2021","journal-title":"J Exp Med"},{"key":"2024103012174530900_CIT0029","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle-mediated brain drug delivery: overcoming blood-brain barrier to treat neurodegenerative diseases","volume":"235","author":"Saraiva","year":"2016","journal-title":"J Control Release"},{"key":"2024103012174530900_CIT0030","first-page":"414","article-title":"Combating malaria with nanotechnology-based targeted and combinatorial drug delivery strategies","volume":"6","author":"Thakkar","year":"2016","journal-title":"Drug Deliv Transl Res"},{"key":"2024103012174530900_CIT0031","doi-asserted-by":"crossref","first-page":"9428","DOI":"10.1039\/D0TB01398F","article-title":"Promising nanomaterials in the fight against malaria","volume":"8","author":"Neves Borgheti-Cardoso","year":"2020","journal-title":"J Mater Chem B"},{"key":"2024103012174530900_CIT0032","first-page":"1","article-title":"Recent advances in particulate anti-malarial drug delivery systems: a review.","volume":"5","author":"Umeyor","year":"2013","journal-title":"Int J Drug Deliv"},{"key":"2024103012174530900_CIT0033","doi-asserted-by":"crossref","first-page":"8887","DOI":"10.1021\/acs.nanolett.9b03774","article-title":"Fenozyme protects the integrity of blood brain barrier against experimental cerebral malaria","volume":"19","author":"Zhao","year":"2019","journal-title":"Nano Lett"},{"key":"2024103012174530900_CIT0034","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1211\/jpp.59.7.0004","article-title":"Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain","volume":"59","author":"Gupta","year":"2007","journal-title":"J Pharm Pharmacol"},{"key":"2024103012174530900_CIT0035","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ijpharm.2016.09.008","article-title":"Nanostructured lipid carriers of artemether\u2013lumefantrine combination for intravenous therapy of cerebral malaria","volume":"513","author":"Prabhu","year":"2016","journal-title":"Int J Pharm"},{"key":"2024103012174530900_CIT0036","doi-asserted-by":"crossref","first-page":"13773","DOI":"10.1039\/C8NR02442A","article-title":"Long circulatory liposomal maduramicin inhibits the growth of Plasmodium falciparum blood stages in culture and cures murine models of experimental malaria","volume":"10","author":"Raza","year":"2018","journal-title":"Nanoscale"},{"key":"2024103012174530900_CIT0037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072722","article-title":"Glucocorticosteroids in nano-sterically stabilized liposomes are efficacious for elimination of the acute symptoms of experimental cerebral malaria","volume":"8","author":"Waknine-Grinberg","year":"2013","journal-title":"PLoS One"},{"key":"2024103012174530900_CIT0038","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/02652048.2018.1441915","article-title":"Ameliorating the in vivo antimalarial efficacy of artemether using nanostructured lipid carriers","volume":"35","author":"Vanka","year":"2018","journal-title":"J Microencapsul"},{"key":"2024103012174530900_CIT0039","doi-asserted-by":"crossref","first-page":"10062","DOI":"10.1038\/s41598-017-10672-9","article-title":"Nanocurcumin is superior to native curcumin in preventing degenerative changes in experimental cerebral malaria","volume":"7","author":"Dende","year":"2017","journal-title":"Sci Rep"},{"key":"2024103012174530900_CIT0040","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1186\/1475-2875-13-501","article-title":"Efficacy of intranasal administration of artesunate in experimental cerebral malaria","volume":"13","author":"Marijon","year":"2014","journal-title":"Malar J"},{"key":"2024103012174530900_CIT0041","doi-asserted-by":"crossref","first-page":"9","DOI":"10.22159\/ijpps.2018v10i9.25408","article-title":"Intranasal delivery of artemether for the treatment of cerebral malaria","volume":"10","author":"Ramteke","year":"2018","journal-title":"Int J Pharm Pharm Sci"},{"key":"2024103012174530900_CIT0042","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3109\/10717544.2014.885999","article-title":"Optimization of artemether-loaded NLC for intranasal delivery using central composite design","volume":"22","author":"Jain","year":"2015","journal-title":"Drug Deliv"},{"key":"2024103012174530900_CIT0043","doi-asserted-by":"crossref","first-page":"e02106","DOI":"10.1128\/AAC.02106-20","article-title":"Efficient treatment of experimental cerebral malaria by an artemisone-SMEDDS system: impact of application route and dosing frequency","volume":"65","author":"Zech","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"2024103012174530900_CIT0044","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jconrel.2021.04.020","article-title":"Intranasal artesunate-loaded nanostructured lipid carriers: a convenient alternative to parenteral formulations for the treatment of severe and cerebral malaria.","volume":"334","author":"Agbo","year":"2021","journal-title":"J Control Release"},{"key":"2024103012174530900_CIT0045","doi-asserted-by":"crossref","first-page":"102114","DOI":"10.1016\/j.jddst.2020.102114","article-title":"Intranasal delivery of polymer-anchored lipid nanoconstructs of artemether-lumefantrine in Plasmodium berghei ANKA murine model","volume":"61","author":"Kaur","year":"2021","journal-title":"J Drug Deliv Sci Technol"},{"key":"2024103012174530900_CIT0046","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ijantimicag.2017.08.025","article-title":"Perillyl alcohol exhibits in vitro inhibitory activity against Plasmodium falciparum and protects against experimental cerebral malaria","volume":"51","author":"Rodriguez","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"2024103012174530900_CIT0047","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1365-2567.2010.03261.x","article-title":"Peroxisome proliferator-activated receptor \u03b4 agonists inhibit T helper type 1 (Th1) and Th17 responses in experimental allergic encephalomyelitis","volume":"130","author":"Kanakasabai","year":"2010","journal-title":"Immunology"},{"key":"2024103012174530900_CIT0048","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1086\/598222","article-title":"Rosiglitazone modulates the innate immune response to Plasmodium falciparum infection and improves outcome in experimental cerebral malaria","volume":"199","author":"Serghides","year":"2009","journal-title":"J Infect Dis"},{"key":"2024103012174530900_CIT0049","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1086\/605431","article-title":"Use of peroxisome proliferator-activated receptor \u03b3 agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial","volume":"49","author":"Boggild","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2024103012174530900_CIT0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-2094-11-9","article-title":"Neuregulin-1 attenuates mortality associated with experimental cerebral malaria","volume":"11","author":"Solomon","year":"2014","journal-title":"J Neuroinflammation"},{"key":"2024103012174530900_CIT0051","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/1475-2875-12-298","article-title":"Azadirachta indica ethanolic extract protects neurons from apoptosis and mitigates brain swelling in experimental cerebral malaria","volume":"12","author":"Bedri","year":"2013","journal-title":"Malar J"},{"key":"2024103012174530900_CIT0052","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1186\/s12936-019-3071-9","article-title":"Terminalia albida treatment improves survival in experimental cerebral malaria through reactive oxygen species scavenging and anti-inflammatory properties","volume":"18","author":"Camara","year":"2019","journal-title":"Malar J"},{"key":"2024103012174530900_CIT0053","doi-asserted-by":"crossref","first-page":"e0192717","DOI":"10.1371\/journal.pone.0192717","article-title":"Doxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators","volume":"13","author":"Schmidt","year":"2018","journal-title":"PLoS One"},{"key":"2024103012174530900_CIT0054","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/s41598-018-19840-x","article-title":"Ethanolic extract of the fungus Trichoderma stromaticum decreases inflammation and ameliorates experimental cerebral malaria in C57BL\/6 mice","volume":"8","author":"Cariaco","year":"2018","journal-title":"Sci Rep"},{"key":"2024103012174530900_CIT0055","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1007\/s00436-018-6016-2","article-title":"\u03b1-Tocopheryl succinate-suppressed development of cerebral malaria in mice","volume":"117","author":"Kume","year":"2018","journal-title":"Parasitol Res"},{"key":"2024103012174530900_CIT0056","doi-asserted-by":"crossref","first-page":"129813","DOI":"10.1016\/j.bbagen.2020.129813","article-title":"Eugenol disrupts Plasmodium falciparum intracellular development during the erythrocytic cycle and protects against cerebral malaria","volume":"1865","author":"Pontes","year":"2021","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"2024103012174530900_CIT0057","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1038\/s41598-017-05609-1","article-title":"Protein tyrosine phosphatase inhibition prevents experimental cerebral malaria by precluding CXCR3 expression on T cells","volume":"7","author":"Van Den Ham","year":"2017","journal-title":"Sci Rep"},{"key":"2024103012174530900_CIT0058","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1186\/s12936-017-2092-5","article-title":"A single rapamycin dose protects against late-tage experimental cerebral malaria via modulation of host immunity, endothelial activation and parasite sequestration","volume":"16","author":"Mejia","year":"2017","journal-title":"Malar J"},{"key":"2024103012174530900_CIT0059","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.intimp.2018.08.041","article-title":"Oral administration of vitamin D and importance in prevention of cerebral malaria","volume":"64","author":"Wu","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"2024103012174530900_CIT0060","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1186\/s12936-017-2109-0","article-title":"Synthetic oleanane triterpenoids enhance blood brain barrier integrity and improve survival in experimental cerebral malaria","volume":"16","author":"Crowley","year":"2017","journal-title":"Malar J"},{"key":"2024103012174530900_CIT0061","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cyto.2016.11.001","article-title":"Minocycline prevents cerebral malaria, confers neuroprotection and increases survivability of mice during Plasmodium berghei ANKA infection","volume":"90","author":"Apoorv","year":"2017","journal-title":"Cytokine"},{"key":"2024103012174530900_CIT0062","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13071-017-2018-7","article-title":"Controlled release of artemisone for the treatment of experimental cerebral malaria","volume":"10","author":"Golenser","year":"2017","journal-title":"Parasit Vectors"},{"key":"2024103012174530900_CIT0063","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3389\/fphar.2020.00846","article-title":"Treatment of experimental cerebral malaria by slow release of artemisone from injectable pasty formulation","volume":"11","author":"Golenser","year":"2020","journal-title":"Front Pharmacol"},{"key":"2024103012174530900_CIT0064","doi-asserted-by":"crossref","first-page":"15957","DOI":"10.1038\/s41598-018-34249-2","article-title":"Reversal of cerebrovascular constriction in experimental cerebral malaria by","volume":"8","author":"Ong","year":"2018","journal-title":"Sci Rep"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/74\/6\/800\/60219154\/rgac003.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/74\/6\/800\/60219154\/rgac003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T17:07:03Z","timestamp":1730308023000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/74\/6\/800\/6569245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":64,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,1]]},"published-print":{"date-parts":[[2022,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jpp\/rgac003","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,6,1]]},"published":{"date-parts":[[2022,6,1]]}}}